VEGFA rSNPs, transcriptional factor binding sites and human disease

Journal of Physiological Sciences

Volumn 64, Issue 1, 2014, Pages 73-76

  Buroker, Norman E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Human disease; Rsnp; Tfbs; Vegfa

Indexed keywords

TRANSCRIPTION FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ALLELE; ANAPHYLACTOID PURPURA; ARTICLE; BINDING SITE; CORONARY ARTERY DISEASE; DIABETIC RETINOPATHY; DISEASES; GENETICS; HUMAN; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BINDING SITES; CORONARY ARTERY DISEASE; DIABETIC RETINOPATHY; DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PURPURA, SCHOENLEIN-HENOCH; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84895829857     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-013-0293-4     Document Type: Article

References (36)

1. Knight JC (2003) Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clin Sci (Lond) 104:493-501
2. Knight JC (2005) Regulatory polymorphisms underlying complex disease traits. J Mol Med (Berl) 83:97-109
3. Wang X, Tomso DJ, Liu X, Bell DA (2005) Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol 207:84-90
4. Wang X, Tomso DJ, Chorley BN, Cho HY, Cheung VG, Kleeberger SR, Bell DA (2007) Identification of polymorphic antioxidant response elements in the human genome. Hum Mol Genet 16:1188-1200
5. Claessens F, Verrijdt G, Schoenmakers E, Haelens A, Peeters B, Verhoeven G, Rombauts W (2001) Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol 76:23-30
6. Hsu MH, Savas U, Griffin KJ, Johnson EF (2007) Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin. J Biol Chem 282: 5225-5236
7. Takai H, Araki S, Mezawa M, Kim DS, Li X, Yang L, Li Z, Wang Z, Nakayama Y, Ogata Y (2008) AP1 binding site is another target of FGF2 regulation of bone sialoprotein gene transcription. Gene 410:97-104
8. Buroker NE, Huang JY, Barboza J, Ledee DR, Eastman RJ Jr, Reinecke H, Ning XH, Bassuk JA, Portman MA (2012) The adaptor-related protein complex 2, alpha 2 subunit (AP2alpha2) gene is a peroxisome proliferator-activated receptor cardiac target gene. Protein J 31:75-83
9. Huang CN, Huang SP, Pao JB, Hour TC, Chang TY, Lan YH, Lu TL, Lee HZ, Juang SH, Wu PP, Huang CY, Hsieh CJ, Bao BY (2012) Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy. J Intern Med 271:499-509
10. Huang CN, Huang SP, Pao JB, Chang TY, Lan YH, Lu TL, Lee HZ, Juang SH, Wu PP, Pu YS, Hsieh CJ, Bao BY (2012) Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy. Ann Oncol 23:707-713
11. Yu B, Lin H, Yang L, Chen K, Luo H, Liu J, Gao X, Xia X, Huang Z (2012) Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans. J Mol Med (Berl) 90:1333-1342 1
12. Wu J, Richards MH, Huang J, Al-Harthi L, Xu X, Lin R, Xie F, Gibson AW, Edberg JC, Kimberly RP (2011) Human FasL gene is a target of beta-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions. PLoS One 6:e26143
13. Alam M, Pravica V, Fryer AA, Hawkins CP, Hutchinson IV (2005) Novel polymorphism in the promoter region of the human nerve growth-factor gene. Int J Immunogenet 32:379-382 1
14. Rueda B, Gonzalez-Gay MA, Lopez-Nevot MA, Garcia A, Fernandez- Arquero M, Balsa A, Pablos JL, Pascual-Salcedo D, de la Concha EG, Gonzalez-Escribano MF, Martin J (2005) Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. Hum Immunol 66:864-868
15. Rueda B, Perez-Armengol C, Lopez-Lopez S, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2006) Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schonlein purpura. J Rheumatol 33:69-73
16. Xie J, Yi L, Xu ZF, Mo XM, Hu YL, Wang DJ, Ren HZ, Han B, Wang Y, Yang C, Zhao YL, Shi DQ, Jiang YZ, Shen L, Qiao D, Chen SL, Yu BJ (2007) VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies. Eur J Hum Genet 15:1246-1251
17. Galecki P, Galecka E, Maes M, Orzechowska A, Berent D, Talarowska M, Bobinska K, Lewinski A, Bienkiewicz M, Szemraj J (2013) Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development. Prog Neuropsychopharmacol Biol Psychiatry 45:117-124
18. Cui QT, Li Y, Duan CH, Zhang W, Guo XL (2013) Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility. Gene 521:217-221
19. Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PE, Ray DW (2008) VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 49:3611-3616
20. Yuan Q, Zuo X, Jia J (2009) Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han. Neurosci Lett 457:133-136
21. Yang JW, Hutchinson IV, Shah T, Fang J, Min DI (2011) Gene polymorphism of vascular endothelial growth factor -1,154 G[A is associated with hypertensive nephropathy in a Hispanic population. Mol Biol Rep 38:2417-2425
22. Buroker NE, Ning XH, Zhou ZN, Li K, Cen WJ, Wu XF, Zhu WZ, Scott CR, Chen SH (2013) VEGFA SNPs and transcriptional factor binding sites associated with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau. J Physiol Sci 63:183-193 2
23. Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A (2008) JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res 36:D102-D106
24. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32:D91-D94
25. Sandelin A, Wasserman WW, Lenhard B (2004) ConSite: webbased prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 32:W249-W252
26. Buroker NE, Ning XH, Zhou ZN, Li K, Cen WJ, Wu XF, Zhu WZ, Scott CR, Chen SH (2012) AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau. Int J Hematol 96:200-213
27. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2005) A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 32:1737-1741
28. Lamani E, Wu Y, Dong J, Litaker MS, Acevedo AC, MacDougall M (2009) Tissue- and cell-specific alternative splicing of NFIC. Cells Tissues Organs 189:105-110 2
29. Pennisi E (2011) The biology of genomes. Disease risk links to gene regulation. Science 332:1031
30. Kumar V, Wijmenga C, Withoff S (2012) From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Semin Immunopathol 34:567-580
31. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106:9362-9367
32. Kumar V, Westra HJ, Karjalainen J, Zhernakova DV, Esko T, Hrdlickova B, Almeida R, Zhernakova A, Reinmaa E, Vosa U, Hofker MH, Fehrmann RS, Fu J, Withoff S, Metspalu A, Franke L, Wijmenga C (2013) Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS genetics 9:e1003201
33. Chorley BN, Wang X, Campbell MR, Pittman GS, Noureddine MA, Bell DA (2008) Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies. Mutat Res 659:147-157
34. Prokunina L, Alarcon-Riquelme ME (2004) Regulatory SNPs in complex diseases: their identification and functional validation. Expert Rev Mol Med 6:1-15
35. Buckland PR (2006) The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochim Biophys Acta 1762:17-28
36. Sadee W, Wang D, Papp AC, Pinsonneault JK, Smith RM, Moyer RA, Johnson AD (2011) Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy. Clin Pharmacol Ther 89:355-365